comparemela.com

Latest Breaking News On - Concentra biosciences - Page 2 : comparemela.com

Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals

As previously announced on December 22, 2023, Concentra Biosciences, LLC and its wholly owned subsidiary, Concentra Merger Sub II, Inc. , entered into a merger agreement with Theseus.

United statesConcentra merger sub ii incConcentra biosciencesTheseus pharmaceuticals incMorrow sodaliBroadridge corporate issuer solutionsConcentra merger subTheseus pharmaceuticalsPrice perBase priceContingent value rightsMerger agreementAdditional price per shareCash amountCorporate issuer solutionsTender offer statement

Cooley s 2023 Life Sciences M&A Year in Review: Potent Mix of Creativity and Resilience Spurs Activity Heading Into 2024 | Cooley LLP

In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024. While the year saw.

United statesConcentra biosciencesBristol myer squibbDechra pharmaSyneos healthMerck kgaCare healthMerck kgaaBristol myers squibbAmerican association for cancer researchCerevel therapeuticsGracell biotechnologiesCarmot therapeuticsHorizon therapeuticsFederal trade commissionAmerican association

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates PGTI, X, THRX, AYX -January 23, 2024 at 02:46 pm EST

NEW YORK, Jan. 23, 2024 /PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or.

Zachary halperDaniel sadehConcentra biosciencesUnited states steel corporationAlteryx incTheseus pharmaceuticals incHalper sadehPrnewswire halper sadehInnovations incNippon steel corporationClearlake capital groupStates steel corporationInsight partnersAlteryx class

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates PGTI, X, THRX, AYX

/PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws.

Zachary halperDaniel sadehNippon steel corporationClearlake capital groupUnited states steel corporationConcentra biosciencesInnovations incPrnewswire halper sadehAlteryx incHalper sadehTheseus pharmaceuticals incStates steel corporationInsight partnersAlteryx classHalper sadeh llp

SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates PGTI, KRTX, THRX, GRCL - Gracell Biotechnologies (NASDAQ:GRCL), Karuna Therapeutics (NASDAQ:KRTX)

NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary

Zachary halperDaniel sadehGracell biotechnologies incHalper sadehInnovations incBristol myers squibbConcentra biosciencesTheseus pharmaceuticals incKaruna therapeutics incMasonite international corporationMasonite international

vimarsana © 2020. All Rights Reserved.